19-39502951-C-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_203486.3(DLL3):​c.546C>G​(p.Ala182Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.318 in 1,451,786 control chromosomes in the GnomAD database, including 75,995 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A182A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.28 ( 6461 hom., cov: 33)
Exomes 𝑓: 0.32 ( 69534 hom. )

Consequence

DLL3
NM_203486.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0910

Publications

8 publications found
Variant links:
Genes affected
DLL3 (HGNC:2909): (delta like canonical Notch ligand 3) This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
DLL3 Gene-Disease associations (from GenCC):
  • spondylocostal dysostosis 1, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive spondylocostal dysostosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 19-39502951-C-G is Benign according to our data. Variant chr19-39502951-C-G is described in ClinVar as Benign. ClinVar VariationId is 260780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.091 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.333 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_203486.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DLL3
NM_203486.3
MANE Select
c.546C>Gp.Ala182Ala
synonymous
Exon 4 of 9NP_982353.1
DLL3
NM_016941.4
c.546C>Gp.Ala182Ala
synonymous
Exon 4 of 8NP_058637.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DLL3
ENST00000356433.10
TSL:2 MANE Select
c.546C>Gp.Ala182Ala
synonymous
Exon 4 of 9ENSP00000348810.4
DLL3
ENST00000205143.4
TSL:1
c.546C>Gp.Ala182Ala
synonymous
Exon 4 of 8ENSP00000205143.3
DLL3
ENST00000600437.1
TSL:1
n.626C>G
non_coding_transcript_exon
Exon 4 of 6

Frequencies

GnomAD3 genomes
AF:
0.281
AC:
42702
AN:
151790
Hom.:
6462
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.172
Gnomad AMI
AF:
0.306
Gnomad AMR
AF:
0.289
Gnomad ASJ
AF:
0.293
Gnomad EAS
AF:
0.125
Gnomad SAS
AF:
0.342
Gnomad FIN
AF:
0.382
Gnomad MID
AF:
0.417
Gnomad NFE
AF:
0.336
Gnomad OTH
AF:
0.299
GnomAD2 exomes
AF:
0.297
AC:
20055
AN:
67630
AF XY:
0.301
show subpopulations
Gnomad AFR exome
AF:
0.132
Gnomad AMR exome
AF:
0.275
Gnomad ASJ exome
AF:
0.279
Gnomad EAS exome
AF:
0.0793
Gnomad FIN exome
AF:
0.381
Gnomad NFE exome
AF:
0.315
Gnomad OTH exome
AF:
0.330
GnomAD4 exome
AF:
0.323
AC:
419378
AN:
1299888
Hom.:
69534
Cov.:
37
AF XY:
0.324
AC XY:
207298
AN XY:
640080
show subpopulations
African (AFR)
AF:
0.163
AC:
4266
AN:
26106
American (AMR)
AF:
0.285
AC:
6497
AN:
22794
Ashkenazi Jewish (ASJ)
AF:
0.286
AC:
6381
AN:
22312
East Asian (EAS)
AF:
0.111
AC:
3149
AN:
28366
South Asian (SAS)
AF:
0.326
AC:
22653
AN:
69508
European-Finnish (FIN)
AF:
0.392
AC:
12700
AN:
32422
Middle Eastern (MID)
AF:
0.371
AC:
1413
AN:
3806
European-Non Finnish (NFE)
AF:
0.332
AC:
345569
AN:
1040894
Other (OTH)
AF:
0.312
AC:
16750
AN:
53680
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
16877
33755
50632
67510
84387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11472
22944
34416
45888
57360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.281
AC:
42699
AN:
151898
Hom.:
6461
Cov.:
33
AF XY:
0.285
AC XY:
21182
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.172
AC:
7120
AN:
41498
American (AMR)
AF:
0.289
AC:
4408
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.293
AC:
1016
AN:
3470
East Asian (EAS)
AF:
0.125
AC:
644
AN:
5160
South Asian (SAS)
AF:
0.344
AC:
1659
AN:
4824
European-Finnish (FIN)
AF:
0.382
AC:
4013
AN:
10504
Middle Eastern (MID)
AF:
0.414
AC:
121
AN:
292
European-Non Finnish (NFE)
AF:
0.336
AC:
22817
AN:
67858
Other (OTH)
AF:
0.295
AC:
623
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1600
3200
4799
6399
7999
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.192
Hom.:
455
Bravo
AF:
0.267
Asia WGS
AF:
0.226
AC:
781
AN:
3456

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 21, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 22, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Spondylocostal dysostosis 1, autosomal recessive Benign:3
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Syndactyly Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
6.1
DANN
Benign
0.60
PhyloP100
-0.091
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8106337; hg19: chr19-39993591; COSMIC: COSV52696025; COSMIC: COSV52696025; API